Serine hydroxymethyltransferase 1 promoter hypermethylation increases the risk of essential hypertension
ConclusionOur findings indicate thatSHMT1 promoter hypermethylation increases the risk of EH and may be a promising biomarker for EH.
Source: Journal of Clinical Laboratory Analysis - Category: Laboratory Medicine Authors: Guodong Xu,
Changyi Wang,
Xiuru Ying,
Fanqian Kong,
Huihui Ji,
Jinshun Zhao,
Xiaohong Zhang,
Shiwei Duan,
Liyuan Han,
Li Li Tags: RESEARCH ARTICLE Source Type: research
More News: Databases & Libraries | Folic Acid | Genetics | Hypertension | Laboratory Medicine | Vitamin B9